Showing 1 - 10 of 20
'Quick Win' policies are paying off
News, Apinya Wipatayotin, Published on 24/10/2025
» Public Health Minister Pattana Prompat said yesterday that the ministry's "Quick Win" policies are advancing as planned, with several initiatives already showing tangible results.
Govt to tackle dialysis issues
News, Apinya Wipatayotin, Published on 03/10/2025
» Newly appointed Public Health Minister Pattana Promphat has pledged to improve dialysis services for more than 100,000 patients nationwide within the next two months.
Hospital sees breakthrough in stem cell transplant for cancer
News, Apinya Wipatayotin, Published on 02/05/2025
» Rajavithi Hospital has successfully performed its first stem cell transplantation on a patient diagnosed with multiple myeloma (MM), a form of cancer, marking a significant milestone in the hospital's efforts to advance life-saving medical technologies.
Wissanu set to take on new role on Thursday
News, Post Reporters, Published on 30/05/2024
» Former deputy prime minister Wissanu Krea-ngam is expected to report to work on Thursday after being appointed as an adviser to the Secretariat of the Cabinet to help with the government's legal affairs, according to a source.
Rajavithi achieves 1st for state hospital
News, Apinya Wipatayotin, Published on 18/01/2024
» Rajavithi Hospital has become the first state-run hospital to successfully perform a simultaneous liver-kidney transplant on a patient, the Department of Medical Services (DMS) says.
A bargain in saving lives from malaria
News, Peter Singer, Published on 21/12/2023
» In 2021, malaria caused 619,000 deaths, 77% of which were children under five, and 96% of them in Africa. But now, after decades of research -- and several false dawns -- a malaria vaccine known as R21/Matrix-M (henceforth just R21) has been shown to be effective in 70-78% of cases. Although three doses are required before that level of protection is reached, and a booster is needed one year later, the vaccine, developed at the University of Oxford and the Serum Institute of India, is cheap. It can be produced for US$2-$4 (70-140 baht) per dose -- comparable to the cost of other childhood vaccines.
Fresh spike drives up bed needs
News, Post Reporters, Published on 14/12/2022
» More hospitals have reopened Covid-19 wards as infections are rising, thus prompting the need for more hospital beds, according to the Department of Disease Control (DDC).
500,000 may need LAAB jabs
News, Apinya Wipatayotin, Published on 28/07/2022
» There are more than 500,000 immunocompromised people in Thailand who may need long-acting antibodies (LAAB) to guard against Covid-19, said Public Health Minister Anutin Charvirakul on Wednesday.
Evusheld therapy gets FDA nod
News, Post Reporters, Published on 30/06/2022
» The Food and Drug Administration (FDA) has approved for emergency use from Monday AstraZeneca's Evusheld, a combination monoclonal antibody injection therapy that provides added protection against Covid-19 prior to virus exposure.
Antibody mix earns top bill
News, Post Reporters, Published on 22/06/2022
» The cabinet has reduced the AstraZeneca vaccine budget in favour of purchasing the pharmaceutical giant's long-acting antibody treatments instead.